Drug: infliximab, recombinant Quarter: 2016Q3
Total Records: 276 Number of Pages: 14
DRUGNAME | PT | EventCount |
---|---|---|
INFLIXIMAB, RECOMBINANT | Herpes simplex | 1 |
INFLIXIMAB, RECOMBINANT | Herpes virus infection | 1 |
INFLIXIMAB, RECOMBINANT | Horner's syndrome | 1 |
INFLIXIMAB, RECOMBINANT | Hyperhidrosis | 1 |
INFLIXIMAB, RECOMBINANT | Hypertensive crisis | 1 |
INFLIXIMAB, RECOMBINANT | Hypotension | 1 |
INFLIXIMAB, RECOMBINANT | Ileal stenosis | 1 |
INFLIXIMAB, RECOMBINANT | Immune reconstitution inflammatory syndrome associated tuberculosis | 1 |
INFLIXIMAB, RECOMBINANT | Immunosuppression | 1 |
INFLIXIMAB, RECOMBINANT | Inflammatory bowel disease | 1 |
INFLIXIMAB, RECOMBINANT | Injection site reaction | 1 |
INFLIXIMAB, RECOMBINANT | Interstitial lung disease | 1 |
INFLIXIMAB, RECOMBINANT | Intestinal ischaemia | 1 |
INFLIXIMAB, RECOMBINANT | Intestinal obstruction | 1 |
INFLIXIMAB, RECOMBINANT | Intestinal ulcer | 1 |
INFLIXIMAB, RECOMBINANT | Iron deficiency anaemia | 1 |
INFLIXIMAB, RECOMBINANT | Kidney duplex | 1 |
INFLIXIMAB, RECOMBINANT | Latent tuberculosis | 1 |
INFLIXIMAB, RECOMBINANT | Lower respiratory tract infection | 1 |
INFLIXIMAB, RECOMBINANT | Lung disorder | 1 |
Total Records: 276 Number of Pages: 14